Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial have?
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial has 173 citations in the OpenAlex counts ScholarIQ stores.
When was Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial published?
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial has 2020 year in the ScholarIQ index.
What is the open-access status of Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial?
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial has hybrid oa status in the ScholarIQ index.
What is the DOI of Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial?
The DOI for Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial is on the source record.
What is the PMID of Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial?
The PMID for Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial is on the source record.
What is the OpenAlex record for Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial?
The OpenAlex for Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial is on the source record.